JD Health International Inc. Share Price Other OTC
Equities
JDHIF
KYG5074A1004
Drug Retailers
Sales 2024 * | 62.11B 8.61B 718B | Sales 2025 * | 72.72B 10.08B 841B | Capitalization | 87.92B 12.18B 1,017B |
---|---|---|---|---|---|
Net income 2024 * | 2.41B 334M 27.88B | Net income 2025 * | 3.18B 441M 36.83B | EV / Sales 2024 * | 1.08 x |
Net cash position 2024 * | 20.92B 2.9B 242B | Net cash position 2025 * | 28.41B 3.94B 329B | EV / Sales 2025 * | 0.82 x |
P/E ratio 2024 * |
36.6
x | P/E ratio 2025 * |
27.8
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 32.32% |
Latest transcript on JD Health International Inc.
Managers | Title | Age | Since |
---|---|---|---|
En Lin Jin
CEO | Chief Executive Officer | 44 | 06/21/06 |
Deng Hui
DFI | Director of Finance/CFO | 38 | 11/23/11 |
Ming King Chiu
SEC | Corporate Secretary | 47 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Ying Wu
BRD | Director/Board Member | 65 | 07/22/07 |
Qiang Dong Liu
CHM | Chairman | 52 | 14/20/14 |
Qing Qing Yi
BRD | Director/Board Member | 52 | 21/20/21 |
1st Jan change | Capi. | |
---|---|---|
-33.90% | 14.89B | |
-28.07% | 6.54B | |
+13.39% | 6.37B | |
-9.19% | 6.03B | |
-0.44% | 4.73B | |
+59.80% | 4.57B | |
-9.15% | 3.82B | |
-10.72% | 3.51B | |
-5.96% | 3.07B |